Skip to main content
SpringerLink
Log in

Cytogenetic Abnormalities Associated with Endocrine Neoplasia

  • Chapter
Human Cytogenetic Cancer Markers

Part of the book series: Contemporary Biomedicine ((CB,volume 13))

Abstract

During the past decade, cytogenetic studies of solid human neoplasms have come of age. Although technically more difficult and often ambiguous in comparison with cytogenetic studies of leukemias and lymphomas (1) cytogenetic studies of many solid tumors have yielded valuable insights into tumor pathogenesis and prognosis. In addition, in the last decade we have seen increasing application of molecular genetic techniques to the study of cancer, which has contributed greatly to our understanding of mechanisms controlling cell growth. Specific genetic alterations responsible for the pathogenesis of a number of neoplasms have been identified.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Teyssier JR. The chromosomal analysis of human solid tumors. A triple challenge. Cancer Genet Cytogenet 37: 103-125, 1989.

    PubMed  CAS  Google Scholar 

  2. Arnold A. Parathyroid adenomas: clonality in benign neoplasia. In: Cossman, J. (ed.), Molecular Gentics in Cancer Diagnosis. New York: Elsevier: pp. 398–408, 1990.

    Google Scholar 

  3. Arnold A, Kim HG: Clonal loss of one chromosome 11 in a parathyroid adenoma. J Clin Endocrinol Metabol 69: 496–4199, 1989.

    CAS  Google Scholar 

  4. Arnold A, Kim HG, Gaz RD, Eddy RL, Fukushima Y, Byers M G, Shows TB: Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. J Clin Invest 83: 2034–2040, 1989.

    PubMed  CAS  Google Scholar 

  5. Friedman E, De Marco L, Gejman PV, Norton JA, Bale AE, Aurbach GD, Marx SJ: Allelic loss from chromosome 11 in parathyroid tumors. Cancer Res 52: 6804–6809, 1992.

    PubMed  CAS  Google Scholar 

  6. Caruso DR, O’Dorisio TM, Mazzaferri EL: Multiple endocrine neoplasia. Curr Opin Oncol 3: 103–108, 1991.

    PubMed  CAS  Google Scholar 

  7. Larsson C, Nordenskjold M: Multiple endocrine neoplasia. Cancer Surv 9: 703–723, 1990.

    PubMed  CAS  Google Scholar 

  8. Larsson C, Nordenskjold M: Family screening in multiple endocrine neoplasia type 1 (MEN 1). Ann Medicine 26: 191–198, 1994.

    CAS  Google Scholar 

  9. Bystrom C, Larsson C, Blomberg C, Sandelin K, Falkmer U, Skogseid B, Werner S, Nordenskjold M: Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. Proc Natl Acad Sci USA 87: 1968–1972, 1990.

    PubMed  CAS  Google Scholar 

  10. Brandi ML: Parathyroid tumor biology in familial multiple endocrine neoplasia type 1: a model for cancer development. Henry Ford Hosp Med J 40: 181–185, 1992.

    PubMed  CAS  Google Scholar 

  11. Radford DM, Ashley SW, Wells SA Jr, Gerhard DS: Loss of heterozygosity of markers on chromosome 11 in tumors from patients with multiple endocrine neoplasia syndrome type 1. Cancer Res 50: 6529–6533, 1990.

    PubMed  CAS  Google Scholar 

  12. Nakamura Y, Larsson C, Julier C, Bystrom C, Skogseid B, Wells S, Carlson M, Taggart T, O’Connell P: Localization of the genetic defect in multiple endocrine neoplasia type 1 within a small region of chromosome 11. Am J Hum Genet 44: 751–755, 1989.

    PubMed  CAS  Google Scholar 

  13. Szabo J, Heath B, Hill VM, Jackson CE, Zarbo RJ, Mallette LE, Chew SL, Besser GM, Thakker RV, Huff V: Hereditary hyperparathyroidismjaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q2l-q31. Am J Hum Genet 56: 944-950, 1995.

    PubMed  CAS  Google Scholar 

  14. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM, Arnold A: A novel cyclin encoded by a bcll-linked candidate oncogene. Nature 350: 512–515, 1991.

    PubMed  CAS  Google Scholar 

  15. Zukerberg LR, Yang WI, Gadd M, Thor AD, Koerner FC, Schmidt EV, Arnold A: Cyclin Dl (PRAD1) protein expression in breast cancer-approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin Dl oncogene. Modern Pathol 8: 560–567, 1995.

    CAS  Google Scholar 

  16. Henry I, Grandjouan S, Coullin P, Barnchard F, Huerre-Jeanpierre G, Glaser T, Lenoir G, Chaussain JL, Junien C: Tumor-specific loss of 11p15.5 alleles in delllp 13 Wilms tumor and familial adrenocortical carcinoma. Proc Natl Acad Sci USA 86: 3247–3251, 1989.

    PubMed  CAS  Google Scholar 

  17. Byrne JA, Simms LA, Little MH, Algar EM, Smith PJ: Three non-overlapping regions of chromosome arm 11p allele loss identified in infantile tumors of adrenal and liver. Genes Chromosome Cancer 8: 104–111, 1993.

    CAS  Google Scholar 

  18. Beckers A, Abs R, Willems PJ, van der Auwera B, Kovacs K, Reznik M: Aldosterone-secreting adrenal adenoma as part of multiple endocrine neoplasia type 1 (MEN1): loss of heterozygosity for polymorphic chromosome 11 deoxyribonucleic acid markers, including the MEN1 locus. J Clin Endocrinol Metabol 75: 564–570, 1992.

    Google Scholar 

  19. Iida A, Blake K, Tunny T, Klemm S, Stowasser M, Hayward N, Gordon R, Imai T: Allelic losses on chromosome band 11q13 in aldosterone-producing adrenal tumors. Genes Chromosome Cancer 12: 73–75, 1995.

    CAS  Google Scholar 

  20. Malkin D: p53 and the Li-Fraumeni syndrome. Biochem Biophys Acta 1198: 197–213, 1994.

    PubMed  Google Scholar 

  21. Malkin D: p53 and the Li-Fraumeni syndrome. Cancer Genet Cytogenet 66: 83–92, 1993.

    PubMed  CAS  Google Scholar 

  22. Ohgaki H, Kleihues P, Heitz PU: p53 mutations in sporadic adrenocortical tumors. Intl J Cancer 54: 408–410, 1993.

    CAS  Google Scholar 

  23. Chang F, Syrjanen S, Syrjanen K: Implications of the p53 tumor-suppressor gene in clinical oncology. J Clin Oncol 13: 1009–1022, 1995.

    PubMed  CAS  Google Scholar 

  24. Lane DP: p53 and human cancers. Br Med Bull 50: 582–599, 1994.

    PubMed  CAS  Google Scholar 

  25. Levine AJ, Perry ME, Chang A, Silver A, Dittmer D, Wu M, Welsh D: The 1993 Walter Hubert Lecture: the role of the p53 tumoursuppressor gene in tumorigenesis. Br J Cancer 69: 409–416, 1994.

    PubMed  CAS  Google Scholar 

  26. Latif F, Tory K, Gnarra J, Yao M, Duh F-M, Orcutt ML, Stackhous T, Kuzmin I, Modi W, Geil L, Schmidt L, Zhou F, Li H, Wei MH, Chen F, Glenn G, Choyke P, Walther MM, Weng Y, Duan DSR, Dean M, Glavac D, Richards FM, Crossey PA, Ferguson-Smith MA, Le Paslier D, Chumakov I, Cohen D, Chinault AC, Maher ER, Linehan WM, Zbar B, Lerman MI: Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260: 1317–1320, 1993.

    PubMed  CAS  Google Scholar 

  27. Kibel A, Iliopoulos O, Decaprio JA, Kaelin WG: Binding of the VonHippel-Lindau tumor suppressor protein to elongin B and C. Science 269: 1444–1446, 1995.

    PubMed  CAS  Google Scholar 

  28. Krumm A, Meulia T, Groudine M: Common mechanisms for the control of eukaryotic transcriptional elongation. Bioessays 15: 659–665, 1993.

    PubMed  CAS  Google Scholar 

  29. Frischauf AM: Positional cloning uncovers a new old oncogene. Human Mol Genet 2: 847, 848, 1993.

    Google Scholar 

  30. Moley JF, Brother MB, Fong CT, White PS, Baylin SB, Nelkin B, Wells SA, Brodeur GM: Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes. Cancer Res 52: 770–774, 1992.

    PubMed  CAS  Google Scholar 

  31. Yang KP, Nguyen CV, Castillo SG, Samaan NA: Deletion mapping on the distal third region of chromosome 1p in multiple endocrine neoplasia type IIA. Anticancer Res 10: 527–533, 1990.

    PubMed  CAS  Google Scholar 

  32. Khosla S, Patel VM, Hay ID, Schaid DJ, Grant CS, van Heerden JA, Thibodeau SN: Loss of heterocygosity suggests mulitple genetic alterations in phaeochromocytoma and medullary thyroid carcinomas. J Clin Invest 87: 1691–1699, 1991.

    PubMed  CAS  Google Scholar 

  33. Butler MG, Rames LJ, Joseph GM: Cytogenetic studies of individuals from four kindreds with multiple endocrine neoplasia type II syndrome. Cancer Genet Cytogenet 28: 253–260, 1987.

    PubMed  CAS  Google Scholar 

  34. Zatterale A, Stabile M, Nunziata V, Di Giovanni G, Vecchione R: Multiple endocrine neoplasia type 2 (Sipple’s syndrome): clinical and cytogenetic analysis of a kindred. J Med Genet 21: 108–111, 1984.

    PubMed  CAS  Google Scholar 

  35. Babu VR, van Dyke DL, Jackson CE: Chromosome 20 deletions in human endocrine neoplasia types 2A and 2B: a double blind study. Proc Natl Acad Sci USA 81: 2525–2528, 1984.

    PubMed  CAS  Google Scholar 

  36. Tanaka N, Nishisho I, Yamamoto M, Miya A, Shin E, Karakawa K, Fujita S, Kobayashi T, Rouleau GA, Mori T: Loss of heterozygosity on the long arm of chromosome 22 in pheochromocytoma. Genes Chromosome Cancer 5: 399–03, 1992.

    CAS  Google Scholar 

  37. Van Dekken H, Bosman FT, Teijgeman R, Vissers CJ, Tersteeg TA, Vooijs GP, Verhofstad AA: Identification of numerical chromosome aberrations in archival tumours by in situ hybridization to routine paraffin sections: evaluation of 23 phaeochromocytomas. J Pathol 171: 161–171, 1993.

    PubMed  Google Scholar 

  38. Klein FA, Kay S, Ratliss JE, White FKH, Newsome HH: Flow cytometric determinations of ploidy and proliferation patterns of adrenal neoplasms: an adjunct to histological classification. J Urol 134: 862–866, 1985.

    PubMed  CAS  Google Scholar 

  39. Hosaka Y, Rainwater LM, Grant CS, Farrow GM, van Heerden JA, Lieber MM: Phaeochromocytoma: nuclear deoxyribunucleic acid patterns studied by flow cytometry. Surgery 100: 1003–1008, 1986.

    PubMed  CAS  Google Scholar 

  40. Amberson JB, Vaughan ED, Gray CF, Naus GJ: Flow cytometric determination of nuclear DNA content in benign adrenal phaeochromocy tomas. Urology 30: 102–104, 1987.

    PubMed  CAS  Google Scholar 

  41. Nativ O, Grant CS, Sheps SG, O’Fallon JR, Farrow GM, van Heerden JA, Lieber MM: The clinical significance of nuclear DNA ploidy pattern in 184 patients with phaeochromocytoma. Cancer 69: 2683–2687, 1992.

    PubMed  CAS  Google Scholar 

  42. Martinez AJ: The pathology of non-functional pituitary adenomas. Pathol Res Practice 183: 613–616, 1988.

    CAS  Google Scholar 

  43. Kovacs K, Horvath E: Pathology of pituitary tumors. Endocrinol Metabol Clin North Am 16: 529–551, 1987.

    CAS  Google Scholar 

  44. Mark J: Two benign intracranial tumors with an abnormal chromosomal picture. Acta Neuropathol 14: 174–184, 1969.

    PubMed  CAS  Google Scholar 

  45. Anniko M, Holm LE, Tribukait B, Wersall J: Aneuploid DNA pattern in human pituitary adenomas. Arch Oto Rhino Laryngol 230: 1–4, 1981.

    CAS  Google Scholar 

  46. Anniko M, Holm LE, Wersall J: Aggressive pitutitary tumor growth. Arch Oto Rhino Laryngol 238: 53–62, 1983.

    CAS  Google Scholar 

  47. Rey JA, Bello MJ, de Campos JM, Kusak ME, Martinez-Castro P, Benitez J: A case of pituitary adenoma with 58 chromosomes. Cancer Genet Cytogenet 23: 171–174, 1986.

    PubMed  CAS  Google Scholar 

  48. Dietrich CU, Pandis N, Bjerre P, Schroder HD, Heim S: Simple numerical chromosome aberrations in two pituitary adenomas. Cancer Genet Cytogenet 69: 118–121, 1993.

    PubMed  CAS  Google Scholar 

  49. Capra E, Rindi G, Santi G, Spina MP, Scappaticci S: Chromosome abnormalities in a case of pituitary adenoma. Cancer Genet Cytogenet 68: 140–142, 1993.

    PubMed  CAS  Google Scholar 

  50. Rock JP, Babu VR, Drumheller T, Chason J: Cytogenetic findings in pituitary adenoma: results of a pilot study. Surg Neurol 40: 224–229, 1993.

    PubMed  CAS  Google Scholar 

  51. Boggild MD, Jenkinson S, Pistorello M, Boscaro M, Scanarini M, Perrett CW, Thakker RV, Clayton RN: Molecular genetic studies of sporadic pituitary tumors. J Clin Endocrinol Metabol 78: 387–392, 1994.

    CAS  Google Scholar 

  52. Yoshimoto K, Iwahana H, Kubo K, Saito S, Itakura M: Allele loss on chromosome 11 in a pituitary tumor from a patient with multiple endocrine neoplasia type 1. Jpn J Cancer Res 82: 886–889, 1991.

    PubMed  CAS  Google Scholar 

  53. Thakker RV, Pook MA, Wooding C, Boscaro M, Scanarini M, Clayton RN: Association of somatotrophinomas with loss of alleles on chromosome 11 and with gsp mutations. J Clin Invest 91: 2815–2821, 1993.

    PubMed  CAS  Google Scholar 

  54. Spada A, Vallar L, Faglia G: Cellular alterations in pituitary tumors. Eur J Endocrinol 130: 43–52, 1994.

    PubMed  CAS  Google Scholar 

  55. Narod SA, Sobol H, Nakamura Y, Calmettes C, Baulieu JL, Bigorgne JC, Couette J, de Gennes JL, Duprey J: Linkage analysis of hereditary thyroid carcinoma with and without pheochromocytoma. Hum Genet 83: 353–358, 1989.

    PubMed  CAS  Google Scholar 

  56. Ledger GA, Khosla S, Lindor NM, Thibodeau SN, Gharib H: Genetic testing in the diagnosis and management of multiple endocrine neoplasia type II. Ann Int Med 122: 118–124, 1995.

    PubMed  CAS  Google Scholar 

  57. Kubo K, Yoshimoto K, Yokogoshi Y, Tsuyuguchi M, Saito S: Loss of heterozygosity on chromosome 1p in thyroid adenoma and medullary carcinoma, but not in papillary carcinoma. Jpn J Cancer Res 82: 1097–1103, 1991.

    PubMed  CAS  Google Scholar 

  58. Mathew CG, Smith BA, Thorpe K, Wong Z, Royle NJ, Jeffreys AJ, Ponder BA: Deletion of genes on chromosome 1 in endocrine neoplasia. Nature 328: 524–526, 1987.

    PubMed  CAS  Google Scholar 

  59. Samaan NA, Yang KP, Schultz P, Hickey RC: Diagnosis, management, and pathogenetic studies in medullary thyroid carcinoma syndrome. Henry Ford Hosp Med J 37: 132–137, 1989.

    PubMed  CAS  Google Scholar 

  60. Takai S, Tateishi H, Nishisho I, Miki T, Motomura K, Miyauchi A, Ikeuchi T, Yamamoto K, Okazaki M: Loss of genes on chromosome 22 in medullary thyroid carcinoma and pheochromocytoma. Jpn J Cancer Res 78: 894–898, 1987.

    PubMed  CAS  Google Scholar 

  61. Wurster-Hill DH, Noll WW, Bircher LY, Devlin J, Schultz E: A cytogenetic study of familial medullary carcinoma of the thyroid. Cancer Res 46: 2134–2138, 1986.

    PubMed  CAS  Google Scholar 

  62. Cooley LD, Elder FFB, Knuth A, Gagel RF: Cytogenetic characterization of three human and three rat medullary thyroid carcinoma cell lines. Cancer Genet Cytogenet 80: 138–149, 1995.

    PubMed  CAS  Google Scholar 

  63. Le Coniat M, Vecchione D, Pacot A, Bernheim A, Berger R, Gardet P: Cytogenetic studies on patients with medullary carcinoma of the thyroid. Cancer Genet Cytogenet 25: 303–307, 1987.

    PubMed  Google Scholar 

  64. Hay ID: Cytometric DNA ploidy analysis in thyroid cancer. Diagn Oncol 1: 181–185, 1991.

    Google Scholar 

  65. Teyssier JR, Liautaud-Roger F, Ferre D, Patey M, Dufer J: Chromosomal changes in thyroid tumors. Relation with DNA content, karyotypic features, and clinical data. Cancer Genet Cytogenet 50: 249–263, 1990.

    PubMed  CAS  Google Scholar 

  66. Roque L, Gomes P, Correia C, Soares P, Soares J, Castedo S: Thyroid nodular hyperplasia: chromosomal studies in 14 cases. Cancer Genet Cytogenet 69: 31–34, 1993.

    PubMed  CAS  Google Scholar 

  67. Beige G, Thode B, Bullerdiek J, Bartnitzke S: Aberrations of chromosome 19. Do they characterize a subtype of benign thyroid adenomas? Cancer Genet Cytogenet 60: 23–26, 1992.

    Google Scholar 

  68. Bondeson L, Bengtsson A, Bondeson AG, Dahlenfors R, Grimelius L, Mark J: Chromosome studies in thyroid neoplasia. Cancer 64: 680–685, 1989.

    PubMed  CAS  Google Scholar 

  69. Herrmann MA, Hay ID, Bartelt DH, Jr., Ritland SR, Dahl RJ, Grant CS, Jenkins RB: Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers. J Clin Invest 88: 1596–1604, 1991.

    PubMed  CAS  Google Scholar 

  70. Taruscio D, Carcangiu ML, Ried T, Ward DC: Numerical chromosomal aberrations in thyroid tumors detected by double fluorescence in situ hybridization. Genes Chromosome Cancer 9: 180–185, 1994.

    CAS  Google Scholar 

  71. Bartnitzke S, Herrmann ME, Lobeck H, Zuschneid W, Neuhaus P: Cytogenetic findings on eight follicular thyroid adenomas including one with a t(10;19). Cancer Genet Cytogenetics 39: 65–68, 1989.

    CAS  Google Scholar 

  72. Roque L, Castedo S, Gomes P, Soares P, Clode A, Soares J: Cytogenetic findings in 18 follicular thyroid adenomas. Cancer Genet Cytogenet 67: 1–6, 1993.

    PubMed  CAS  Google Scholar 

  73. Sozzi G, Miozzo M, Cariani TC, Bongarzone I, Pilotti S, Pierotti MA: A t(2;3)(q12–13;p24–25) in follicular thyroid adenomas. Cancer Genet Cytogenet 64: 38–41, 1992.

    PubMed  CAS  Google Scholar 

  74. Herrmann MA, Hay ID, Bartelt DH Jr, Spurbeck JL, Dahl RJ, Grant CS: Cytogenetics of six follicular thyroid adenomas including a case report of an oxyphil variant with t(8;14)(q13;q24.1). Cancer Genet Cytogenet 56: 231–235, 1991.

    PubMed  CAS  Google Scholar 

  75. Johansson B, Heim S, Mandahl N, Mertens F, Mitelman F: Trisomy 7 in nonneoplastic cells. Genes Chromosome Cancer 6: 199–205, 1993.

    CAS  Google Scholar 

  76. Beige G, Thode B, Bullerdiek J, Bartnitzke S: Deletion of part of the long arm of chromosome 13 as the only karyotypic aberration in a follicular thyroid adenoma. Cancer Genet Cytogenet 56: 277–280, 1991.

    Google Scholar 

  77. Olah E, Balogh E, Bojan F, Juhasz F, Stenszky V, Farid NR: Cytogenetic analyses of three papillary carcinomas and a follicular adenoma of the thyroid. Cancer Genet Cytogenet 44: 119–129, 1990.

    PubMed  CAS  Google Scholar 

  78. Roque L, Castedo S, Clode A, Soares J: Translocation t(5; 19): a recurrent change in thyroid follicular adenoma. Genes Chromsome Cancer 4: 346, 347, 1992.

    Google Scholar 

  79. Dal Cin P, Sneyers W, Aly MS, Segers A, Ostijn F, Van Damme B, VanDen Berghe H: Involvement of 19q13 in follicular thyroid adenoma. Cancer Genet Cytogenet 60: 99–101, 1992.

    Google Scholar 

  80. Matsuo K, Tang SH, Fagin JA: Allelotype of human thyroid tumors: loss of chromosome 11 q 13 sequences in follicular neoplasms. Mol Endocrinol 5: 1873–1879, 1991.

    PubMed  CAS  Google Scholar 

  81. Boland CR: The biology of colorectal cancer. Implications for pretreatment and follow-up management. Cancer 71: 4180–4186, 1993.

    PubMed  CAS  Google Scholar 

  82. Jenkins RB, Hay ID, Herath JF, Schultz CG, Spurbeck JL, Grant CS, Dewald GW: Frequent occurrence of cytogenetic abnormalities in sporadic nonmedullary thyroid carcinoma. Cancer 66: 1213–1220, 1990.

    PubMed  CAS  Google Scholar 

  83. Roque L, Castedo S, Clode A, Soares J: Deletion of 3p25→pter in a primary follicular thyroid carcinoma and its metastasis. Genes Chromosome Cancer 8: 199–203, 1993.

    CAS  Google Scholar 

  84. Gazdar AF: The molecular and cellular basis of human lung cancer. Anticancer Res 14: 261–267, 1994.

    PubMed  CAS  Google Scholar 

  85. Kratzke RA, Shimizu E, Kaye FJ: Oncogenes in human lung cancer. Cancer Treat Res 63: 61–85, 1992.

    PubMed  CAS  Google Scholar 

  86. Kovacs G: Molecular differential pathology of renal cell tumours. Histopathology 22: 1–8, 1993.

    PubMed  CAS  Google Scholar 

  87. Sekido Y, Bader S, Latif F, Gnarra JR, Gazdar AF, Linehan WM, Zbar B, Lerman MI, Minna JD: Molecular analysis of the von Hippel-Lindau disease tumor suppressor gene in human lung cancer cell lines. Oncogene 9: 1599–1604, 1994.

    PubMed  CAS  Google Scholar 

  88. Minna JD: The molecular biology of lung cancer pathogenesis. Chest 103: 449S–456S, 1993.

    PubMed  CAS  Google Scholar 

  89. Foster K, Prowse A, van den Berg A, Fleming S, Hulsbeek MM, Crossey PA, Richards FM, Cairns P, Affara NA, Ferguson-Smith MA, et al.: Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in nonfamilial clear cell renal carcinoma. Human Mol Genet 3: 2169–2173, 1994.

    CAS  Google Scholar 

  90. Gnarra JR, Lerman MI, Zbar B, Linehan WM: Genetics of renalcell carcinoma and evidence for a critical role for von Hippel-Lindau in renal tumorigenesis. Semin Oncol 22: 3–8, 1995.

    PubMed  CAS  Google Scholar 

  91. Fand NR, Shi Y, Zou M: Molecular basis of thyroid cancer. Endocrine Rev 15: 202–232, 1994.

    Google Scholar 

  92. Rosai J, Carcangiu ML, DeLellis RA: Atlas of Tumor Pathology. Tumors of the Thyroid Gland. Washington, DC: Armed Forces Institute of Pathology.

    Google Scholar 

  93. Antonini P, Venuat AM, Caillou B, Berger R, Schlumberger M, Bernheim A, Parmentier C: Cytogenetic studies on 19 papillary thyroid carcinomas. Genes Chromosome Cancer 5: 206–211, 1992.

    CAS  Google Scholar 

  94. Herrmann ME, Talpos GB, Mohamed AN, Saxe A, Ratner S, Lalley PA, Wolwan SR: Genetic markers in thyroid tumors. Surgery 110: 941–947 1991.

    PubMed  CAS  Google Scholar 

  95. Sozzi G, Bongarzone I, Miozzo M, Cariani CT, Mondellini P, Calderone C, Pilotti S, Pierotti MA, Delia Porta G: Cytogenetic and molecular genetic characterization of papillary thyroid carcinomas. Genes Chromosome Cancer 5: 212–218, 1992.

    CAS  Google Scholar 

  96. Pierotti MA, Santoro M, Jenkins RB, Sozzi G, Bongarzone I, Grieco M, Monzini N, Miozzo M, Herrmann MA, Fusco A, Hay ID, Delia Porta G, Vecchio G: Characterization of an inversion on the long arm of chromo-some 10 juxtaposing D10S 170 and ret and creating the oncogenic sequence ret/ptc. Proc Natl Acad Sci USA 89: 1616–1620, 1992.

    PubMed  CAS  Google Scholar 

  97. Bongarzone I, Butti MG, Coronelli S, Borrello MG, Santoro M, Pilotti S, Fusco A, Delia Porta G, Pierotti MA: Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas. Cancer Res 54: 2979–2985, 1994.

    PubMed  CAS  Google Scholar 

  98. Grieco M, Cerrato A, Santoro M, Fusco A, Melillo RM, Vecchio G: Cloning and characterization of H4 (D10S 170), a gene involved in RET rearrangements in vivo. Oncogene 9: 2531–2535, 1994.

    PubMed  CAS  Google Scholar 

  99. Tong Q, Li YS, Smanik PA, Fithian LJ, Xing SH, Mazzaferri EL, Jhiang SM: Characterization of the promoter region and oligomerization domain of H4 (D10S 170), a gene frequently rearranged with the ret protooncogene. Oncogene 10: 1781–1787, 1995.

    PubMed  CAS  Google Scholar 

  100. Sozzi G, Bongarzone I, Miozzo M, Borrello MG, Blutti MG, Pilotti S, Pierotti MA: A t(10; 17) translocation creates the RET/PTC2 chimeric transforming sequence in papillary thyroid carcinoma. Genes Chromosome Cancer 9: 244–250, 1994.

    CAS  Google Scholar 

  101. Amorosi A, Cicchi P, Tonelli F, Falchetti A, Bandini S, Tanini A, Brandi ML: Multiple endocrine neoplasia type 1: a model for the analysis of tumor clonality and its biological significance. Serono Symp 83: 89–98, 1991.

    CAS  Google Scholar 

  102. Minoletti F, Butti MG, Coronelli S, Miozzo M, Sozzi G, Pilotti S, Tunnacliffe A, Pierotti MA, Bongarzone I: The two genes generating RET/PTC3 are localized in chromosomal band 10q 11.2. Genes Chromsome Cancer 11: 51–57, 1994.

    CAS  Google Scholar 

  103. Viglietto G, Chiappetta G, Martineztello FJ, Fukunaga FH, Tallini G, Rigopoulou D, Visconti R, Mastro A, Santoro M, Fusco A: RET/PTC oncogene activation is an early event in thyroid carcinogenesis. Oncogene 11: 1207–1210, 1995.

    PubMed  CAS  Google Scholar 

  104. Santoro M, Carlomagno F, Hay ID, Herrmann MA, Grieco M, Melillo R, Pierotti MA, Bongarzone I, Delia Porta G, Berger N, Peix JL, Paulin C, Fabien N, Jenkins RB, Fusco A: A RET oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. J Clin Invest 89: 1517–1522, 1992.

    PubMed  CAS  Google Scholar 

  105. Nikiforov Y, Gnepp DR: Pediatric thyroid cancer after the Chernobyl disaster. Pathomorphologic study of 84 cases (1991–1992) from the Republic of Belarus. Cancer 74: 748–766, 1994.

    PubMed  CAS  Google Scholar 

  106. Ito T, Seyama T, Iwamoto KS, Hayashi T, Mizuno T, Tsuyama N, Dohi K, Nakamura N, Akiyama M: In vitro irradiation is able to cause RET oncogene rearrangement. Cancer Res 53: 2940–2943, 1993.

    PubMed  CAS  Google Scholar 

  107. Ito T, Seyama T, Iwamoto KS, Mizuno T, Tronko ND, Komissarenko IV, Cherstovoy ED, Satow Y, Takeichi N, Dohi K, et al.: Activated RET oncogene in thyroid cancers of children from areas contaminated by Chernobyl accident. Lancet 344: 259, 1994.

    PubMed  CAS  Google Scholar 

  108. Fugazzola L, Pilotti S, Pinchera A, Vorontsova TV, Mondellini P, Bongarzone I, Greco A, Astakhova L, Butti MG, Demidchik EP, Pacini F, Pierotti MA: Oncogenic rearrangement of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident. Cancer Res 55: 5617–5620, 1995.

    PubMed  CAS  Google Scholar 

  109. DeLellis RA: Biology of disease. Multiple endocrine neoplasia syndromes revisited: clinical, morphologic and molecular features. Lab Invest 72: 494–505, 1995.

    PubMed  CAS  Google Scholar 

  110. Ponder BA: The gene causing multiple endocrine neoplasia type 2 (MEN 2). Ann Med 26: 199–203, 1994.

    PubMed  CAS  Google Scholar 

  111. Larsson C, Skogseid B, Oberg K, Nakamura Y, Nordenskjold M: Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332: 85–87, 1988.

    PubMed  CAS  Google Scholar 

  112. Friedman E, DeMarco L, Bale AE, Aurbach GD, Spiegel AM, Marx SJ: Allelic loss in parathyroid tumors: localizing the meni gene to a small region on 11q13. Serono Symp 83: 69–76, 1991.

    Google Scholar 

  113. Skogseid B, Larsson C, Oberg K: Genetic and clinical characteristics of multiple endocrine neoplasia type 1. Acta Oncologica 30: 485–488, 1991.

    PubMed  CAS  Google Scholar 

  114. Thakker RV: The role of molecular genetics in screening for multiple endocrine neoplasia type 1. Endocrinol Metabol Clin North Am 23: 117–135, 1994.

    CAS  Google Scholar 

  115. Scappaticci S, Maraschio P, del Ciotto N, Fossati GS, Zonta AF: Chromosome abnormalities in lymphocytes and fibroblasts of subjects with multiple endocrine neoplasia type 1. Cancer Genet Cytogenet 52: 85–92, 1991.

    PubMed  CAS  Google Scholar 

  116. Hecht F, Hecht BK: Unstable chromosomes in heritable tumor syndromes. Multiple endocrine neoplasia type 1 (MENI). Cancer Genet Cytogenet 52: 131–134, 1991.

    PubMed  CAS  Google Scholar 

  117. Scappaticci S, Brandi ML, Capra E, Cortinovis M, Maraschio PF: Cytogenetics of multiple endocrine neoplasia syndrome. II. Chromosome abnormalities in an insulinoma and a glucagonoma from two subjects with MENI. Cancer Genet Cytogenet 63: 17–21, 1992.

    PubMed  CAS  Google Scholar 

  118. Emmertsen K, Lamm LU, Rasmussen KZ, Elbrond O, Hansen HH, Henningsen K, Jorgensen J, Petersen GB: Linkage and chromosome study of multiple endocrine neoplasia Ha. Cancer Genet Cytogenet 9: 251–259, 1983.

    PubMed  CAS  Google Scholar 

  119. Simpson NE, Kidd KK, Goodfellow PJ, McDermid H, Myers S, Kidd JRJ, Duncan AM, Farrer LA, Brasch K, et al.: Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage. Nature 328: 528–530, 1987.

    PubMed  CAS  Google Scholar 

  120. Mathew CG, Chin KS, Easton DF, Thorpe K, Carter C, Liou GI, Fong SL, Haak H, Kruseman AC, et al.: A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10. Nature 328: 527–528, 1987.

    PubMed  CAS  Google Scholar 

  121. Lichter JB, Wu J, Miller D, Goodfellow PJ, Kidd KK: A high-resolution meiotic mapping panel for the pericentromeric region of chromosome 10. Genomics 13: 607–612, 1992.

    PubMed  CAS  Google Scholar 

  122. Nelkin BD, Nakamura Y, White RW, de Bustros AC, Herman J, Wells SAJ, Baylin SB: Low incidence of loss of chromosome 10 in sporadic and hereditary human medullary thyroid carcinoma. Cancer Res 49: 4114–4119, 1989.

    PubMed  CAS  Google Scholar 

  123. Okazaki M, Miya A, Tanaka N, Miki T, Yamamoto M, Motomura KM, Mori T, Takai S: Allele loss on chromosome 10 and point mutation of ras oncogenes are infrequent in tumors of MEN 2A. Henry Ford Hosp Med J 37: 112–115, 1989.

    PubMed  CAS  Google Scholar 

  124. Wells SA, Chi DD, Toshima K, Dehner LP, Coffin CM, Dowton B, Ivanovich JL, DeBenedetti MK, Dilley WG, Moley JF, Norton JA, Donis-Keller H: Predictive DNA testing and prohylactic thyroidectomy in patients at tisk for multiple endocrine neoplasia type 2A. Ann Surg 220: 237–250, 1994.

    PubMed  Google Scholar 

  125. Houldsworth J, Chaganti RS: Comparative genomic hybridization: an overview. Am J Pathol 145: 1253–1260, 1994.

    PubMed  CAS  Google Scholar 

  126. Lisitsyn N, Lisitsyn N, Wigler M: Cloning the differences between two complex genomes. Science 259: 946–951, 1993.

    PubMed  CAS  Google Scholar 

  127. Lisitsyn NA, Lisitsina NM, Dalbagni G, Barker P, Sanchez CA, Gnarra J, Linehan WM, Reid BJ, Wigler MH: Comparative genomic analysis of tumors: detection of DNA losses and amplification. Proc Natl Acad Sci USA 92: 151–155, 1995.

    PubMed  CAS  Google Scholar 

  128. Lisitsyn NA, Segre JA, Kusumi K, Lisitsyn NM, Nadeau JH, Frankel WN, Lander ES: Direct isolation of polymorphic markers linked to a trait by genetically directed representational difference analysis. Nature Genet 6: 57–63, 1994.

    PubMed  CAS  Google Scholar 

  129. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 266: 1865–1869, 1994.

    PubMed  CAS  Google Scholar 

  130. Telenius H, Pelmear AH, Tunnacliffe A, Carter NP, Behmel A, Nordenskjold M, Pfragner R, Ponder BA: Cytogenetic analysis by chromosome painting using DOP-PCR amplified flow-sorted chromosomes. Genes Chromosome Cancer 4: 257–263, 1992.

    CAS  Google Scholar 

Download references

Authors
  1. Stefan K. G. Grebe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Norman L. Eberhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert B. Jenkins
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pathology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA

    Sandra R. Wolman MD

  2. Department of Pathology, Albany Medical College, Albany, NY, USA

    Stewart Sell MD

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Humana Press Inc.

About this chapter

Cite this chapter

Grebe, S.K.G., Eberhardt, N.L., Jenkins, R.B. (1997). Cytogenetic Abnormalities Associated with Endocrine Neoplasia. In: Wolman, S.R., Sell, S. (eds) Human Cytogenetic Cancer Markers. Contemporary Biomedicine, vol 13. Humana Press. https://doi.org/10.1007/978-1-4612-3952-9_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-3952-9_14

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-4612-8437-6

  • Online ISBN: 978-1-4612-3952-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation